Delivery Order SPE2DR25D1053-SPE2DR26FV329
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,144.62 to AmerisourceBergen Drug Corp for the supply of Lyrica 75 mg capsules (90-count units) on November 24, 2025, with a completion date of November 25, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Lyrica 150 mg capsules (90-count units) valued at $1,723.91. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by December 31, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Lyrica 300 mg capsules (90-count units) with a ceiling value of $1,713.51. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Lyrica 225 mg capsules (90-count units) with a contract ceiling value of $7,503.32. This is a firm fixed-price delivery order with an ultimate completion date of January 6, 2026, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a $3,322.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lyrica 75 mg capsules in unit dose packaging (100 count) on December 18, 2025, with completion scheduled for December 19, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime contractor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $3,119.78 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on December 16, 2025, with completion expected by December 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds...
- The Defense Logistics Agency awarded a delivery order valued at $1,183.60 to AmerisourceBergen Drug Corp for Lyrica 100 mg capsules (90-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a...
- The Defense Logistics Agency awarded a delivery order valued at $2,279.00 to AmerisourceBergen Drug Corp for Lyrica 25 mg capsules (90-count) on November 17, 2025, with completion targeted for November 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 75 mg capsules (90-count units) under a firm fixed-price contract valued at $4,977.56, with a completion date of December 30, 2025. This non-set-aside award was competitively procured and represents a single delivery order from AmerisourceBergen's broader relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lyrica 100 mg capsules (quantity 90) with a ceiling value of $11,191.13. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside designation. The ultimate completion date is...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV329Delivery Order
The Defense Logistics Agency awarded a $1,196.02 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 7, 2026, for the supply of Lyrica 75 mg capsules (90 count). This non-set-aside contract represents a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with a completion date of January 8, 2026. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor serving federal healthcare systems including military treatment facilities and veteran healthcare programs. The company's extensive portfolio under the DLA contract encompasses a wide range of pharmaceutical products, specialty medications, vaccines, and medical supplies across multiple therapeutic domains. The supply of Lyrica, a neurological treatment medication, supports the Defense Health Agency and other federal healthcare system requirements through Amerisourcebergen's comprehensive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/6/26 |